Literature DB >> 19594424

Human Cytomegalovirus US28: a functionally selective chemokine binding receptor.

Jennifer Vomaske1, J A Nelson, Daniel N Streblow.   

Abstract

Chemokines are small cytokines that are part of a large family of molecules that bind to G-protein coupled receptors, which, as a family, are the most widely targeted group of molecules in the treatment of disease. Chemokines are critical for recruiting and activating the cells of the immune system during inflammation especially during viral infections. However, a number of viruses including the large herpes virus human cytomegalovirus (HCMV) encode mechanisms to impede the effects of chemokines or has gained the ability to use these molecules to its own advantage. The Human Cytomegalovirus (HCMV)-encoded chemokine receptor US28 is the best characterized of the four unique chemokine receptor-like molecules found in the HCMV genome. US28 has been studied as an important virulence factor for HCMV-mediated vascular disease and, more recently, in models of HCMV-associated malignancy. US28 is a rare multi-chemokine family binding receptor with the ability to bind ligands from two distinct chemokine classes. Ligand binding to US28 activates cell-type and ligand-specific signaling pathways leading to cellular migration, which is an important example of receptor functional selectivity. Additionally, US28 has been demonstrated to constitutively activate phospholipase C (PLC) and NF-kB signaling pathways. Understanding the structure/function relationships between US28, its ligands and intracellular signaling molecules will provide essential clues for effective pharmacological targeting of this multifunctional chemokine receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594424      PMCID: PMC3496389          DOI: 10.2174/187152609789105696

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  71 in total

Review 1.  Functional selectivity and classical concepts of quantitative pharmacology.

Authors:  Jonathan D Urban; William P Clarke; Mark von Zastrow; David E Nichols; Brian Kobilka; Harel Weinstein; Jonathan A Javitch; Bryan L Roth; Arthur Christopoulos; Patrick M Sexton; Keith J Miller; Michael Spedding; Richard B Mailman
Journal:  J Pharmacol Exp Ther       Date:  2006-06-27       Impact factor: 4.030

2.  Synthesis and pharmacological characterization of novel inverse agonists acting on the viral-encoded chemokine receptor US28.

Authors:  Janneke W Hulshof; Henry F Vischer; Mark H P Verheij; Silvina A Fratantoni; Martine J Smit; Iwan J P de Esch; Rob Leurs
Journal:  Bioorg Med Chem       Date:  2006-07-14       Impact factor: 3.641

Review 3.  The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state.

Authors:  G Enrico Rovati; Valérie Capra; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2006-12-27       Impact factor: 4.436

Review 4.  GRKs and arrestins: regulators of migration and inflammation.

Authors:  Anne Vroon; Cobi J Heijnen; Annemieke Kavelaars
Journal:  J Leukoc Biol       Date:  2006-08-30       Impact factor: 4.962

5.  Differential activation of G-proteins by mu-opioid receptor agonists.

Authors:  Zuzana Saidak; Katherine Blake-Palmer; Debbie L Hay; John K Northup; Michelle Glass
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

6.  G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer.

Authors:  Jonathan D Violin; Xiu-Rong Ren; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

7.  Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis.

Authors:  David Maussang; Dennis Verzijl; Marijke van Walsum; Rob Leurs; Jens Holl; Olivier Pleskoff; Detlef Michel; Guus A M S van Dongen; Martine J Smit
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

8.  The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer.

Authors:  Jasper M Boomker; T Hauw The; Lou F M H de Leij; Martin C Harmsen
Journal:  Virus Res       Date:  2006-01-31       Impact factor: 3.303

9.  G protein-coupled receptor (GPCR) kinase 2 regulates agonist-independent Gq/11 signaling from the mouse cytomegalovirus GPCR M33.

Authors:  Joseph D Sherrill; William E Miller
Journal:  J Biol Chem       Date:  2006-11-06       Impact factor: 5.157

Review 10.  Agonist-selective mechanisms of GPCR desensitization.

Authors:  E Kelly; C P Bailey; G Henderson
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

View more
  24 in total

Review 1.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

Review 2.  Viral manipulation of the host immune response.

Authors:  Allison Christiaansen; Steven M Varga; Juliet V Spencer
Journal:  Curr Opin Immunol       Date:  2015-07-10       Impact factor: 7.486

3.  The HCMV US28 vGPCR induces potent Gαq/PLC-β signaling in monocytes leading to increased adhesion to endothelial cells.

Authors:  Shu-En Wu; William E Miller
Journal:  Virology       Date:  2016-08-04       Impact factor: 3.616

4.  Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype.

Authors:  Liliana Soroceanu; Lisa Matlaf; Vladimir Bezrookove; Loui Harkins; Roxanne Martinez; Mary Greene; Patricia Soteropoulos; Charles S Cobbs
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

5.  Human cytomegalovirus pUS27 G protein-coupled receptor homologue is required for efficient spread by the extracellular route but not for direct cell-to-cell spread.

Authors:  Christine M O'Connor; Thomas Shenk
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

6.  Genomic sequencing and characterization of cynomolgus macaque cytomegalovirus.

Authors:  Angie K Marsh; David O Willer; Aruna P N Ambagala; Misko Dzamba; Jacqueline K Chan; Richard Pilon; Jocelyn Fournier; Paul Sandstrom; Michael Brudno; Kelly S MacDonald
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

Review 7.  The battle between virus and host: modulation of Toll-like receptor signaling pathways by virus infection.

Authors:  Shin-Ichi Yokota; Tamaki Okabayashi; Nobuhiro Fujii
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

8.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

9.  Human Cytomegalovirus Latency: Approaching the Gordian Knot.

Authors:  Felicia Goodrum
Journal:  Annu Rev Virol       Date:  2016-08-04       Impact factor: 10.431

Review 10.  Human cytomegalovirus encoded homologs of cytokines, chemokines and their receptors: roles in immunomodulation.

Authors:  Brian P McSharry; Selmir Avdic; Barry Slobedman
Journal:  Viruses       Date:  2012-10-25       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.